METTL3/IGF2BP1/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC
METTL3/IGF2BP1/CD47 contributes to the sublethal heat treatment induced mesenchymal transition in HCC
复制标题
METTL3/IGF2BP1/CD47 有助于亚致死热处理诱导的 HCC 间质转化
DOI:
10.1016/j.bbrc.2021.01.085
复制
发表时间:
2021-02-12
影响因子:
3.1
通讯作者:
Shu, Minfeng
中科院分区:
文献类型:
--
作者:
Fan, Zhuoyang;Gao, Yang;Shu, Minfeng
Microwave ablation is a first-line treatment of small hepatocellular carcinoma (HCC), while incomplete ablation induces recurrence and metastasis. However, its underlying mechanism remains largely unexplored. Here we reported that sublethal heat treatment (46 degrees C) strongly promoted migration and EMT transition in HCC cells. Mechanistic investigation revealed that compared with 37 degrees C, HCC cells treated with 46 degrees C expressed higher level of CD47. Knockdown of CD47 significantly attenuated sublethal heat treatment stimulated migration and EMT transition. In addition, METTL3 which is the key enzyme of m6A modification was also induced by 46 degrees C treatment and triggered CD47 expression in HCC cells. Moreover, CD47 mRNA degradation was further proved to be stabled in the IGF2BP1-dependent manner. Importantly, sublethal heat treatment stimulated CD47 expression and EMT transition were also confirmed in patient-derived organoid. Taken together, our study suggests that METTL3/IGF2BP1/CD47 mediated EMT transition contributes to the incomplete ablation induced metastasis in HCC cells. Moreover, these findings identify the METTL3/IGF2BP1/CD47 axis as a potential therapeutic target for the microwave ablation and shed new lights on the crosstalk between incomplete heat ablation and RNA methylation. (c) 2021 Elsevier Inc. All rights reserved.